134 related articles for article (PubMed ID: 38175635)
1. Trend towards reduction of transfusion reactions using prestorage leukocyte-reduced and pooled whole blood-derived platelets and cost savings compared with poststorage whole blood-derived random platelets as evidenced by real-time hemovigilance.
Park N; Correa Medina M; Martinez F; Throssel M; Dasgupta A; Knopfelmacher A; Villamin C; Rivas S; Tomczak N; Garg S; Layton L; Klein K
Lab Med; 2024 May; 55(3):251-254. PubMed ID: 38175635
[TBL] [Abstract][Full Text] [Related]
2. A Comparison of Transfusion-Related Adverse Reactions Among Apheresis Platelets, Whole Blood-Derived Platelets, and Platelets Subjected to Pathogen Reduction Technology as Reported to the National Healthcare Safety Network Hemovigilance Module.
Mowla SJ; Kracalik IT; Sapiano MRP; O'Hearn L; Andrzejewski C; Basavaraju SV
Transfus Med Rev; 2021 Apr; 35(2):78-84. PubMed ID: 33934903
[TBL] [Abstract][Full Text] [Related]
3. Effects of prestorage vs poststorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to platelets.
Wang RR; Triulzi DJ; Qu L
Am J Clin Pathol; 2012 Aug; 138(2):255-9. PubMed ID: 22904138
[TBL] [Abstract][Full Text] [Related]
4. Analysis of transfusion reactions associated with prestorage-pooled platelet components.
Tormey CA; Sweeney JD; Champion MH; Pisciotto PT; Snyder EL; Wu Y
Transfusion; 2009 Jun; 49(6):1242-7. PubMed ID: 19389029
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets.
Heddle NM; Blajchman MA; Meyer RM; Lipton JH; Walker IR; Sher GD; Constantini LA; Patterson B; Roberts RS; Thorpe KE; Levine MN
Transfusion; 2002 May; 42(5):556-66. PubMed ID: 12084163
[TBL] [Abstract][Full Text] [Related]
6. Platelet transfusions in children: results of a randomized, prospective, crossover trial of plasma removal and a prospective audit of WBC reduction.
Couban S; Carruthers J; Andreou P; Klama LN; Barr R; Kelton JG; Heddle NM
Transfusion; 2002 Jun; 42(6):753-8. PubMed ID: 12147029
[TBL] [Abstract][Full Text] [Related]
7. Study of acute transfusion reactions in a teaching hospital of Sikkim: A hemovigilance initiative.
Sharma DK; Datta S; Gupta A
Indian J Pharmacol; 2015; 47(4):370-4. PubMed ID: 26285707
[TBL] [Abstract][Full Text] [Related]
8. Prolonged platelet storage associated with increased frequency of transfusion-related adverse events.
Losos M; Biller E; Li J; Blower L; Hamad D; Patel G; Scrape S; Cataland S; Chen J
Vox Sang; 2018 Feb; 113(2):170-176. PubMed ID: 29243264
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets.
Heddle NM; Klama L; Meyer R; Walker I; Boshkov L; Roberts R; Chambers S; Podlosky L; O'Hoski P; Levine M
Transfusion; 1999 Mar; 39(3):231-8. PubMed ID: 10204584
[TBL] [Abstract][Full Text] [Related]
10. Pooled platelet product using the Acrodose plus system: evaluation of feasibility, safety and efficacy.
Sawant RB; Marathe AN
Transfus Apher Sci; 2013 Dec; 49(3):535-8. PubMed ID: 24080148
[TBL] [Abstract][Full Text] [Related]
11. ABO-incompatible platelets are associated with increased transfusion reaction rates.
Malvik N; Leon J; Schlueter AJ; Wu C; Knudson CM
Transfusion; 2020 Feb; 60(2):285-293. PubMed ID: 31912889
[TBL] [Abstract][Full Text] [Related]
12. Transfusion-associated adverse reactions (TAARs) and cytokine accumulations in the stored blood components: the impact of prestorage versus poststorage leukoreduction.
Chang CC; Lee TC; Su MJ; Lin HC; Cheng FY; Chen YT; Yen TH; Chu FY
Oncotarget; 2018 Jan; 9(4):4385-4394. PubMed ID: 29435110
[TBL] [Abstract][Full Text] [Related]
13. Incidence of acute transfusion reactions to platelets in hospitalized pediatric patients based on the US hemovigilance reporting system.
Li N; Williams L; Zhou Z; Wu Y
Transfusion; 2014 Jun; 54(6):1666-72. PubMed ID: 24410992
[TBL] [Abstract][Full Text] [Related]
14. Transfusion reactions after transfusion of platelets stored in PAS-B, PAS-C, or plasma: a nationwide comparison.
van Hout FMA; van der Meer PF; Wiersum-Osselton JC; Middelburg RA; Schipperus MR; van der Bom JG; Kerkhoffs JL
Transfusion; 2018 Apr; 58(4):1021-1027. PubMed ID: 29405304
[TBL] [Abstract][Full Text] [Related]
15. Digitally enabled hemovigilance allows real time response to transfusion reactions.
Villamin C; Bates T; Mescher B; Benitez S; Martinez F; Knopfelmacher A; Correa Medina M; Klein K; Dasgupta A; Jaffray DA; Porter C; Tereffe W; Gallardo L; Kelley J
Transfusion; 2022 May; 62(5):1010-1018. PubMed ID: 35442519
[TBL] [Abstract][Full Text] [Related]
16. Bacterial contamination of platelets for transfusion: strategies for prevention.
Levy JH; Neal MD; Herman JH
Crit Care; 2018 Oct; 22(1):271. PubMed ID: 30367640
[TBL] [Abstract][Full Text] [Related]
17. Febrile nonhemolytic transfusion reactions to platelets.
Heddle NM
Curr Opin Hematol; 1995 Nov; 2(6):478-83. PubMed ID: 9372039
[TBL] [Abstract][Full Text] [Related]
18. Febrile reactions after platelet transfusion: the effect of single versus multiple donors.
Chambers LA; Kruskall MS; Pacini DG; Donovan LM
Transfusion; 1990; 30(3):219-21. PubMed ID: 1967118
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal analysis of annual national hemovigilance data to assess pathogen reduced platelet transfusion trends during conversion to routine universal clinical use and 7-day storage.
Pitman JP; Payrat JM; Park MS; Liu K; Corash L; Benjamin RJ
Transfusion; 2023 Apr; 63(4):711-723. PubMed ID: 36802055
[TBL] [Abstract][Full Text] [Related]
20. Transfusion reactions in pediatric compared with adult patients: a look at rate, reaction type, and associated products.
Oakley FD; Woods M; Arnold S; Young PP
Transfusion; 2015 Mar; 55(3):563-70. PubMed ID: 25145580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
